Laurel Wealth Advisors Inc. bought a new stake in shares of Colgate-Palmolive (NYSE:CL) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 3,289 shares of the company’s stock, valued at approximately $248,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CL. Beach Investment Management LLC. purchased a new position in Colgate-Palmolive during the second quarter valued at $3,954,000. Roosevelt Investment Group Inc. purchased a new position in Colgate-Palmolive during the second quarter valued at $1,044,000. TIAA CREF Investment Management LLC lifted its position in Colgate-Palmolive by 3.7% during the second quarter. TIAA CREF Investment Management LLC now owns 4,725,042 shares of the company’s stock valued at $350,267,000 after purchasing an additional 170,053 shares in the last quarter. Buckingham Capital Management Inc. lifted its position in Colgate-Palmolive by 1.2% during the second quarter. Buckingham Capital Management Inc. now owns 35,291 shares of the company’s stock valued at $2,616,000 after purchasing an additional 420 shares in the last quarter. Finally, HAP Trading LLC lifted its position in Colgate-Palmolive by 109.1% during the second quarter. HAP Trading LLC now owns 55,234 shares of the company’s stock valued at $4,094,000 after purchasing an additional 662,067 shares in the last quarter. Institutional investors own 73.87% of the company’s stock.
In other news, insider Jennifer Daniels sold 902 shares of Colgate-Palmolive stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $75.82, for a total value of $68,389.64. Following the sale, the insider now directly owns 37,788 shares of the company’s stock, valued at $2,865,086.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Daniel B. Marsili sold 5,692 shares of Colgate-Palmolive stock in a transaction dated Wednesday, February 21st. The stock was sold at an average price of $70.19, for a total value of $399,521.48. Following the completion of the sale, the insider now directly owns 41,677 shares in the company, valued at $2,925,308.63. The disclosure for this sale can be found here. Insiders sold 455,707 shares of company stock worth $32,443,427 over the last ninety days. Insiders own 1.02% of the company’s stock.
Shares of Colgate-Palmolive (NYSE CL) opened at $69.62 on Friday. Colgate-Palmolive has a twelve month low of $68.19 and a twelve month high of $77.91. The company has a debt-to-equity ratio of 27.02, a current ratio of 1.36 and a quick ratio of 1.00. The stock has a market capitalization of $60,887.72, a PE ratio of 30.54, a PEG ratio of 2.58 and a beta of 0.79.
Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.75. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The firm had revenue of $3.89 billion for the quarter, compared to analysts’ expectations of $3.92 billion. During the same period in the previous year, the firm posted $0.75 earnings per share. The business’s revenue was up 4.6% compared to the same quarter last year. research analysts anticipate that Colgate-Palmolive will post 3.18 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 15th. Stockholders of record on Friday, April 20th will be issued a $0.42 dividend. This represents a $1.68 annualized dividend and a dividend yield of 2.41%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.40. The ex-dividend date is Thursday, April 19th. Colgate-Palmolive’s payout ratio is 70.18%.
Several equities analysts recently weighed in on CL shares. Deutsche Bank started coverage on Colgate-Palmolive in a research report on Wednesday, December 13th. They set a “hold” rating and a $75.00 target price on the stock. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Monday, January 15th. Macquarie upgraded Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective on the stock in a research report on Tuesday, December 19th. Societe Generale downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price objective on the stock. in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Finally, KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have given a buy rating to the stock. Colgate-Palmolive presently has a consensus rating of “Hold” and an average target price of $77.71.
ILLEGAL ACTIVITY WARNING: “Laurel Wealth Advisors Inc. Buys New Stake in Colgate-Palmolive (CL)” was originally posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this report on another site, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.thelincolnianonline.com/2018/03/17/laurel-wealth-advisors-inc-buys-new-stake-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.